BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23216663)

  • 1. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases.
    van den Reek JM; van Lümig PP; Janssen M; Schers HJ; Hendriks JC; van de Kerkhof PC; Seyger MM; de Jong EM
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):27-33. PubMed ID: 23216663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
    Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E
    J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
    Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L;
    Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
    Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
    Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
    Chakravarty EF; Michaud K; Wolfe F
    J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
    van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
    Amari W; Zeringue AL; McDonald JR; Caplan L; Eisen SA; Ranganathan P
    Rheumatology (Oxford); 2011 Aug; 50(8):1431-9. PubMed ID: 21415022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.
    Lebwohl M; Blum R; Berkowitz E; Kim D; Zitnik R; Osteen C; Wallis WJ
    Arch Dermatol; 2005 Jul; 141(7):861-4. PubMed ID: 16027301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
    Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
    Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
    Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
    Eur J Neurol; 2014 Mar; 21(3):454-8. PubMed ID: 24330255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
    McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
    Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
    Feist A; Lee R; Osborne S; Lane J; Yung G
    J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study.
    Lange E; Blizzard L; Venn A; Francis H; Jones G
    Rheumatology (Oxford); 2016 Sep; 55(9):1594-600. PubMed ID: 27185957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.